Vivos Inc (RDGL)

[doccjc]

RDGL....Time is Ticking on Major Catalysts.

FDA IDE submission for RadioGel human trials at Mayo Clinic is imminent (target: end of Q1 / April 2026).

Strong momentum building:100+ successful IsoPet animal treatments with zero serious adverse events

PrecisionGel delivering precise, localized radiation.

Positive early human data from India (safety + tumor reduction)

One platform with potential across 17+ solid tumor indications.
After IDE approval ...... Mayo trials = true value explosion.
These prices won't last long, imo.